Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin

American Journal of Tropical Medicine and Hygiene

Volumn 57, Issue 4, 1997, Pages 483-486

  Eberhard, Mark L ^a   Hightower, Allen W ^a   Addiss, David G ^a   Lammie, Patrick J ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DIETHYLCARBAMAZINE; IVERMECTIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD LEVEL; DOSE TIME EFFECT RELATION; FILARIASIS; HUMAN; TREATMENT OUTCOME; WUCHERERIA BANCROFTI;

WUCHERERIA BANCROFTI;

EID: 0030868373     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1997.57.483     Document Type: Article

References (18)

1. Ottesen EA, 1985. Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans. Rev Infect Dis 7: 341-356.
2. Weil GJ, Lammie PJ, Richards FO Jr, Eberhard ML, 1991. Changes in circulating parasite antigen level after treatment of Bancroftian filariasis with diethylcarbamazine and ivermectin. J Clin Infect Dis 164: 814-816.
3. Day KP, Spark R, Garner R Raiko A, Wenger JD, Weiss N, Mitchell GF, Alpers MR Kazura JW, 1991. Serologic evaluation of the macrofilaricidal effects of diethylcarbamazine treatment in bancroftian filariasis. Am J Trop Med Hyg 44: 528-535.
4. Kazura J, Greenberg J, Perry R, Weil G, Day K, Alpers M, 1993. Comparison of single-dose diethylcarbamazine and ivermectin for treatment of Bancroftian filariasis in Papua New Guinea. Am J Trop Med Hyg 49: 804-811.
5. Eberhard ML, Lammie PJ, Roberts JM, Lowrie RC, 1989. Ef fectiveness of spaced doses of diethylcarbamazine citrate for the control of bancroftian filariasis. Tropenmed Parasitol 40: 111-113.
6. Addiss DG, Eberhard ML, Lammie PJ, McNeeley MB, Lee SH, McNeeley DF, Spencer HC, 1993. Comparative efficacy clearing-dose and single-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia. Am J Trop Med Hyg 48: 178-185.
7. More SJ, Copeman DB, 1990. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in Bancroftian filariasis. Trop Med Parasitol 41: 403-406.
8. Lammie PJ, Hightower AW, Eberhard ML, 1994. Age-specific prevalence of antigenemia in a Wuchereria bancrofti-exposed population. Am J Trop Med Hyg 57: 348-355.
9. Eberhard ML, Dickerson JW, Hightower AW, Lammie PJ, 1991. Bancroftian filariasis: long-term effects of treatment with diethylcarbamazine (DEC) in a Haitian population. Am J Trop Med Hyg 45: 728-733.
10. Dreyer G, Noroes J, Amaral F, Nen A, Medeiros Z, Coutinho A, Addiss G, 1995. Direct assessment of the adulticidal efficacy of a single dose of ivermectin in Bancroftian filariasis. Trans R Soc Trop Med Hyg 89: 441-443.
11. Dreyer G, Addiss D, Noroes J, Amaral F, Rocha A, Coutinho A, 1996. Ultrasonographic assessment of the adulticidal efficacy of repeat high-dose ivermectin in Bancroftian filariasis. Trop Med Int Health 1: 427-432.
12. Eberhard ML, Hightower AW, McNeeley DF, Lammie PJ, 1992. Long term suppression of microfilaremia following ivermectin treatment. Trans R Soc Trop Med Hyg 86: 287-288.
13. Chodakewitz J, 1995. Ivermectin and lymphatic filariasis: a clinical update. Parasitol Today II: 233-235.
14. Weil GJ, Sethumadhavan KVP, Santhanam S, Jain DC, Ghosh TK, 1988. Persistence of parasite antigenemia following diethylcarbamazine therapy of Bancroftian filariasis. Am J Trop Med Hyg 38: 589-595.
15. Zheng HJ, Tao ZH, Cheng WF, Wang SH, Cheng SZ, Ye YM, Luo LF, Chen XR, Gan GB, Piessens WF, 1991. Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. II. Immunologic changes following treatment. Am J Trop Med Hyg 45: 175-181.
16. Padigel UM, Reddy MIF, Alikhan A, Harinath BC, 1995. Immunomonitoring of filarial patients during DEC therapy in an endemic area: a seven-year follow-up. J Trop Med Hyg 98: 52-56.
17. Weil GJ, Blair LS, Vislocky Ewanciw D, Malatesta PF, 1986. Use of parasite antigen detection to monitor the success of drug therapy in Dirofilaria immifis-infected dogs. J Parasitol 72: 737-740.
18. McCarthy JS, Guinea A, Weil GJ, Ottesen EA, 1995. Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection. J Infect Dis 172: 521-526.